Alternative Data for Aflac
About Aflac
Aflac Inc is a general business holding company and acts as a management company. It offers supplemental health and life insurance in the U.S. and Japan.
| Price | $108.71 |
| Target Price | Sign up |
| Volume | 2,802,774 |
| Market Cap | $56.1B |
| Year Range | $96.53 - $116.84 |
| Dividend Yield | 2.12% |
| PE Ratio | 15.94 |
| Analyst Rating | 23% buy |
| Industry | Insurance |
In the news
NWSL Atlanta expansion team announces 7-year front-of-kit sponsorship deal with Georgia-based AflacFebruary 25 - Yahoo Entertainment |
|
 |
Q4 Rundown: Aflac (NYSE:AFL) Vs Other Life Insurance StocksFebruary 24 - Yahoo |
|
Is It Time To Reassess Aflac (AFL) After Its Recent Share Price Weakness?February 24 - Yahoo |
 |
AFLAC Inc (NYSE:AFL) Shows High Technical and Setup Ratings for a Potential BreakoutFebruary 15 - ChartMill |
|
Aflac Conference: Japan Sales Momentum, Broker-Led U.S. Growth and $4.8B in Dividends, BuybacksFebruary 15 - Yahoo |
|
Has Aflac Incorporated (NYSE:AFL) Stock's Recent Performance Got Anything to Do With Its Financial Health?February 15 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 4.9B | 1.96B | 2.93B | 1.38B | 1.85B | 1.570 |
| Q3 '25 | 4.79B | 2.69B | 2.1B | 1.64B | 2.71B | 2.490 |
| Q2 '25 | 4.22B | 3.04B | 1.18B | 599M | 822M | 1.730 |
| Q1 '25 | 3.45B | 2.96B | 490M | 29M | 145M | 1.660 |
| Q4 '24 | 5.5B | 2.97B | 2.53B | 1.9B | 2.14B | 1.560 |
Insider Transactions View All
| Japan Post Holdings Co., Ltd. filed to sell 52,168,000 shares at $110.2. March 13 '26 |
| LAKE CHARLES D II filed to sell 62,237 shares at $109.9. March 13 '26 |
| Koide Masatoshi filed to sell 86,422 shares at $109.9. March 13 '26 |
| Japan Post Holdings Co., Ltd. filed to sell 52,168,280 shares at $109.5. March 13 '26 |
| Japan Post Holdings Co., Ltd. filed to sell 52,186,100 shares at $111.4. March 12 '26 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
AllstateALL |
$206.17 0.6% | 49 |
 |
ProgressivePGR |
$205.17 0% | 56 |
 |
MetLifeMET |
$67.97 1.2% | 47 |
 |
LemonadeLMND |
$55.15 4.3% | 66 |
 |
Oscar HealthOSCR |
$13.23 1.8% | 34 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Aug 8, 25 | Buy | $1K - $15K |
| Carol Devine Miller |
Apr 11, 25 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
Read more about Aflac (AFL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Aflac
The Market Cap of Aflac is $56.1B.
As of today, Aflac's PE (Price to Earnings) ratio is 15.94.
Currently, the price of one share of Aflac stock is $108.71.
The AFL stock price chart above provides a comprehensive visual representation of Aflac's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aflac shares. Our platform offers an up-to-date AFL stock price chart, along with technical data analysis and alternative data insights.
Yes, Aflac (AFL) offers dividends to its shareholders, with a dividend yield of 2.12%. This dividend yield represents Aflac's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Aflac in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Aflac are Allstate, Progressive, MetLife, Lemonade, and Oscar Health.
